| Jennifer Hardwick, MD | |
|
415 N 26th St, Lafayette, IN 47904-2895 | |
| (765) 446-6562 | |
| Not Available |
| Full Name | Jennifer Hardwick |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 16 Years |
| Location | 415 N 26th St, Lafayette, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245492941 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 125-053989 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Oaks Health Inc | 7315927563 | 51 |
News Archive
In our latest interview, we spoke to Dr. Kathy Trieu about the impact of dairy fats on cardiovascular disease.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network.
A new report from the Government Accountability Office (GAO) that finds "extraordinary price increases" for brand-name drug products from 2000 – 2008 was largely fueled by the "lack of therapeutically equivalent drugs" and "limited competition," underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.
› Verified 7 days ago
| Entity Name | Valley Oaks Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689629990 PECOS PAC ID: 7315927563 Enrollment ID: O20040720001286 |
News Archive
In our latest interview, we spoke to Dr. Kathy Trieu about the impact of dairy fats on cardiovascular disease.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network.
A new report from the Government Accountability Office (GAO) that finds "extraordinary price increases" for brand-name drug products from 2000 – 2008 was largely fueled by the "lack of therapeutically equivalent drugs" and "limited competition," underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Hardwick, MD 415 N 26th St, Lafayette, IN 47904-2895 Ph: (765) 446-6562 | Jennifer Hardwick, MD 415 N 26th St, Lafayette, IN 47904-2895 Ph: (765) 446-6562 |
News Archive
In our latest interview, we spoke to Dr. Kathy Trieu about the impact of dairy fats on cardiovascular disease.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network.
A new report from the Government Accountability Office (GAO) that finds "extraordinary price increases" for brand-name drug products from 2000 – 2008 was largely fueled by the "lack of therapeutically equivalent drugs" and "limited competition," underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.
› Verified 7 days ago
Dr. Dragoslav Gvozdjan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 415 N 26th St Ste 103, Lafayette, IN 47904 Phone: 765-446-6400 | |
Dr. Samuel Horton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3743 Landmark Dr Ste 200, Lafayette, IN 47905 Phone: 765-448-4511 Fax: 765-447-8375 | |
Husain Yusuf Shaath, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2600 Ferry St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7636 | |
Zeinab Tobaa, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 415 N 26th St, Suite 201, Lafayette, IN 47904 Phone: 765-446-6535 | |
Dr. Vernon L Little, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 415 N 26th St, Suite 201, Lafayette, IN 47904 Phone: 765-446-6535 | |
Orland S Gustilo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3660 Rome Dr, Lafayette, IN 47905 Phone: 765-446-9394 Fax: 765-447-8875 |